Evidence map›Paper›PMID 35701062›Full record

Trial reportBMJ open2022

Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial.

Yuto Yamada, Masaki Fujiwara, Taichi Shimazu, Tsuyoshi Etoh, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Maiko Fujimori and 9 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yuto YamadaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Masaki FujiwaraDepartment of Neuropsychiatry, Okayama University Hospital, Okayama, Japan mfujiwara@okayama-u.ac.jp minagaki@med.shimane-u.ac.jp.ORCID 0000-0002-6181-3166
Taichi ShimazuDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID 0000-0001-6000-9830
Tsuyoshi EtohDepartment of Nursing, Shimane University Hospital, Izumo, Japan.
Masafumi KodamaOkayama Psychiatric Medical Center, Okayama, Japan.
Ryuhei SoOkayama Psychiatric Medical Center, Okayama, Japan.
Takanori MatsushitaZikei Hospital, Okayama, Japan.
Yusaku YoshimuraZikei Hospital, Okayama, Japan.
Shigeo HoriiZikei Hospital, Okayama, Japan.
Maiko FujimoriDivision of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID 0000-0003-1639-3390
Hirokazu TakahashiDivision of Screening Assessment and Management, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Naoki NakayaTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Tempei MiyajiDepartment of Clinical Trial Data Management, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shiro HinotsuDepartment of Biostatistics and Data Management, Sapporo Medical University, Sapporo, Japan.
Keita HaradaDepartment of Gastroenterology, Okayama University Hospital, Okayama, Japan.
Hiroyuki OkadaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Yosuke UchitomiGroup for Supportive Care and Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Norihito YamadaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
Masatoshi InagakiDepartment of Psychiatry, Faculty of Medicine, Shimane University, Izumo, Japan mfujiwara@okayama-u.ac.jp minagaki@med.shimane-u.ac.jp.ORCID 0000-0002-9822-8649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe examined the efficacy of case management (CM) interventions to encourage participation in colorectal cancer screening for patients with schizophrenia. This study aimed to clarify patients' acceptability of the intervention and the helpful components of the intervention. Simultaneously, the study aimed to determine the acceptability, appropriateness and feasibility of the intervention from the perspective of psychiatric care providers. STUDY DESIGN AND

settingThis study was a secondary qualitative analysis of a mixed-method randomised controlled trial that evaluated the efficacy of the CM approach to encourage participation in cancer screening for people with schizophrenia. The intervention comprised education and patient navigation for colorectal cancer screening. Interviews were conducted with patients who received the intervention and staff from two psychiatric hospitals in Japan who delivered the intervention.

participantsOf the 172 patients with schizophrenia who participated in the trial, 153 were included. In addition, three out of six providers were included. DATA COLLECTION AND ANALYSIS: Using a structured interview, the case manager asked participants about patient acceptability and the helpful components of the intervention. Content analysis was conducted for the responses obtained, and the number of responses was tabulated by two researchers. For the interviews with the providers, opinions obtained from verbatim transcripts were extracted and summarised.

resultsForty-three of the 56 patients perceived that the intervention was acceptable. For the intervention component, inperson counselling with an explanation of the screening process by psychiatric care providers was most frequently reported by the patients as helpful (48 of the 68 respondents). Psychiatric care providers evaluated the intervention as acceptable, appropriate and easy to understand and administer. However, providing the intervention to all patients simultaneously was considered difficult with the current human resources.

conclusionsThis study showed that the CM intervention was perceived as acceptable by patients and acceptable and appropriate by psychiatric care providers. TRIAL REGISTRATION NUMBER: UMIN000036017.

Indexed as

Colorectal NeoplasmsSchizophreniaCase ManagementEarly Detection of CancerFeasibility StudiesHumansoncologyqualitative researchschizophrenia & psychotic disorders

Identifiers

PMID35701062
PMCPMC9198687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.